PortfoliosLab logoPortfoliosLab logo
VYGR vs. MRNY
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

VYGR vs. MRNY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Voyager Therapeutics, Inc. (VYGR) and YieldMax MRNA Option Income Strategy ETF (MRNY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, VYGR achieves a -7.63% return, which is significantly lower than MRNY's 56.58% return.


VYGR

1D
3.71%
1M
-3.59%
YTD
-7.63%
6M
-16.74%
1Y
10.00%
3Y*
-34.59%
5Y*
-5.51%
10Y*
-12.79%

MRNY

1D
2.91%
1M
5.64%
YTD
56.58%
6M
51.42%
1Y
53.54%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

VYGR vs. MRNY - Yearly Performance Comparison


2026 (YTD)202520242023
VYGR
Voyager Therapeutics, Inc.
-7.63%-30.69%-32.82%23.94%
MRNY
YieldMax MRNA Option Income Strategy ETF
56.58%-35.72%-59.32%18.27%

Correlation

The correlation between VYGR and MRNY is 0.44, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.44

Correlation (All Time)
Calculated using the full available price history since Oct 24, 2023

0.42

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VYGR vs. MRNY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VYGR
VYGR Risk / Return Rank: 4848
Overall Rank
VYGR Sharpe Ratio Rank: 4747
Sharpe Ratio Rank
VYGR Sortino Ratio Rank: 4848
Sortino Ratio Rank
VYGR Omega Ratio Rank: 4646
Omega Ratio Rank
VYGR Calmar Ratio Rank: 4848
Calmar Ratio Rank
VYGR Martin Ratio Rank: 4848
Martin Ratio Rank

MRNY
MRNY Risk / Return Rank: 3434
Overall Rank
MRNY Sharpe Ratio Rank: 3232
Sharpe Ratio Rank
MRNY Sortino Ratio Rank: 3838
Sortino Ratio Rank
MRNY Omega Ratio Rank: 3434
Omega Ratio Rank
MRNY Calmar Ratio Rank: 3737
Calmar Ratio Rank
MRNY Martin Ratio Rank: 2626
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VYGR vs. MRNY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Voyager Therapeutics, Inc. (VYGR) and YieldMax MRNA Option Income Strategy ETF (MRNY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


VYGRMRNYDifference
Sharpe ratioReturn per unit of total volatility

-0.93

Sortino ratioReturn per unit of downside risk

-1.09

Omega ratioGain probability vs. loss probability

1.08

1.21

-0.13

Calmar ratioReturn relative to maximum drawdown

0.27

1.71

-1.44

Martin ratioReturn relative to average drawdown

0.48

3.30

-2.83

VYGR vs. MRNY - Sharpe Ratio Comparison

The current VYGR Sharpe Ratio is 0.15, which is lower than the MRNY Sharpe Ratio of 1.08. The chart below compares the historical Sharpe Ratios of VYGR and MRNY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

VYGR vs. MRNY - Drawdown Comparison

The maximum VYGR drawdown since its inception was -92.11%, which is greater than MRNY's maximum drawdown of -82.15%. Use the drawdown chart below to compare losses from any high point for VYGR and MRNY.


Loading charts...

Drawdown Indicators


VYGRMRNYDifference

Max Drawdown

Largest peak-to-trough decline

-92.11%

-82.15%

-9.96%

Max Drawdown (1Y)

Largest decline over 1 year

-37.71%

-31.53%

-6.18%

Max Drawdown (3Y)

Largest decline over 3 years

-80.49%

Max Drawdown (5Y)

Largest decline over 5 years

-80.49%

Max Drawdown (10Y)

Largest decline over 10 years

-92.11%

Current Drawdown

Current decline from peak

-88.41%

-67.04%

-21.37%

Average Drawdown

Average peak-to-trough decline

-66.91%

-52.78%

-14.13%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.10%

16.25%

+4.85%

Volatility

VYGR vs. MRNY - Volatility Comparison

Voyager Therapeutics, Inc. (VYGR) has a higher volatility of 19.66% compared to YieldMax MRNA Option Income Strategy ETF (MRNY) at 12.97%. This indicates that VYGR's price experiences larger fluctuations and is considered to be riskier than MRNY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


VYGRMRNYDifference

Volatility (1M)

Calculated over the trailing 1-month period

19.66%

12.97%

+6.69%

Volatility (6M)

Calculated over the trailing 6-month period

43.72%

37.72%

+6.00%

Volatility (1Y)

Calculated over the trailing 1-year period

65.19%

49.94%

+15.25%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

80.85%

50.72%

+30.13%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

75.87%

50.72%

+25.15%

Dividends

VYGR vs. MRNY - Dividend Comparison

VYGR has not paid dividends to shareholders, while MRNY's dividend yield for the trailing twelve months is around 102.17%.


PositionTTM202520242023
MRNY
YieldMax MRNA Option Income Strategy ETF
102.17%145.98%178.49%1.75%
VYGR
Voyager Therapeutics, Inc.
0.00%0.00%0.00%0.00%

Frequently Asked Questions


VYGR and MRNY have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

VYGR has higher volatility (19.66%) compared to MRNY (12.97%). In terms of maximum drawdown, VYGR dropped -92.11% vs MRNY's -82.15%.

MRNY currently has the higher Sharpe Ratio (1.08 vs 0.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for VYGR and MRNY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer